drugset / Trial / NCT01189656
A Clinical Study on Therapeutic Double-plasmid Hepatitis B Virus (HBV) DNA Vaccine in Patients With HBeAg-positive Chronic Hepatitis B
Phase 2
Unknown
33 enrolled
The 458 Hospital of Chinese PLA
Guangzhou Baidi Biotechnology Co., Ltd · collabGuangzhou Pharmaceucal Company Limited · collab
RandomizedParallel-groupDouble-blindTreatment
Summary
To preliminarily evaluate the efficiency and safety of therapeutic double- plasmid HBV DNA vaccine on HBeAg-positive, chronic hepatitis B patients, and provide evidence for the next dosing regimen.
Timeline
- Start
- 2009-01
- Primary completion
- 2010-11
- Completion
- 2010-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HBV DNA Vaccine | Vaccine | 1 mg/ml | — |